SUMMARY
Salivary agglutination is an important host defense mechanism to aggregate oral commensal bacteria as well as invading pathogens. Saliva flow and subsequent swallowing more easily clear aggregated bacteria compared with single cells. Phagocytic clearance of bacteria through polymorphonuclear neutrophil granulocytes also seems to increase to a certain extent with the size of bacterial aggregates. To determine a connection between salivary agglutination and the host innate immune response by phagocytosis, an in vitro agglutination assay was developed reproducing the average size of salivary bacterial aggregates. Using the oral commensal Streptococcus gordonii as a model organism, the effect of salivary agglutination on phagocytic clearance through polymorphonuclear neutrophil granulocytes was investigated. Here we describe how salivary aggregates of S. gordonii are readily cleared through phagocytosis, whereas single bacterial cells showed a significant delay in being phagocytosed and killed. Furthermore, before phagocytosis the polymorphonuclear neutrophil granulocytes were able to induce a specific deaggregation, which was dependent on serine protease activity. The data presented suggest that salivary agglutination of bacterial cells leads to an ideal size for recognition by polymorphonuclear neutrophil granulocytes. As a first line of defense, these phagocytic cells are able to recognize the aggregates and de-aggregate them via serine proteases to a more manageable size for efficient phagocytosis and subsequent killing in the phagolysosome. This observed mechanism not only prevents the rapid spreading of oral bacterial cells while entering the bloodstream but would also avoid degranulation of involved polymorphonuclear neutrophil granulocytes, so preventing collateral damage to nearby tissue.
INTRODUCTION
The human oral cavity is a heavily populated habitat (Bik et al., 2010; Ahn et al., 2011; Benitez-Paez et al., 2014) where microbes come into direct contact with the host immune defense system and interface with diverse host tissues (Lang et al., 2010) . Saliva, as the main fluid found in the oral cavity, is the carrier of up to 10 9 bacterial cells per milliliter (Wade, 2013) . Saliva together with the mucus flow originating from the mucosal lining of the oral cavity constitutes the major system molecular oral microbiology maintaining a healthy oral homeostasis (Amerongen & Veerman, 2002) . Besides bacteriostatic and bactericidal functions mediated by salivary components like lactoferrin, histatins, b-defensins, and lysozyme (Amerongen & Veerman, 2002; Lang et al., 2010 ) the salivary flow constantly reduces the abundance of planktonic bacteria by aggregation and subsequent swallowing. The major aggregating components in saliva are salivary agglutinin, the mucins MUC5B and MUC7, and the dimeric immunoglobulin sIgA (Amerongen & Veerman, 2002) , which aggregate single bacterial cells into larger flocs (referred to here as salivary agglutination) for efficient clearance by swallowing. Less well investigated is the interaction of the systemic innate immune system with bacterial cells aggregated by salivary agglutination. Events leading to this interaction occur when the oral mucosal barrier is compromised, not only by surgical (Soldado et al., 1998) or dental procedures, but also by daily oral hygiene (Lucas et al., 2008) or even the ingestion of food (Diener et al., 1964) . The common consequence is a transient bacteraemia (Tomas et al., 2007) , which is usually cleared efficiently by phagocytic cells of the innate immune system (Morris et al., 2007) . However, inefficient clearance constitutes the initial step towards the development of deep tissue abscesses (Ulivieri et al., 2007) or infective endocarditis (Herzberg, 1996; Moreillon et al., 2002; Lick et al., 2005) . Both can lead to septic shock, and the latter can also trigger acute heart failure. Polymorphonuclear neutrophil granulocytes are a major component of the innate immune defense system in the bloodstream and comprise the majority of phagocytic blood granulocytes. In general, blood-circulating polymorphonuclear neutrophil granulocytes are recruited to the site of infection to respond to invading pathogens. When ingested into the phagolysosome, pathogens are usually rapidly killed by a burst of reactive oxygen and nitrogen species, cytolytic proteins, and degradative enzymes (Tapper, 1996) . Polymorphonuclear neutrophil granulocytes also contain different types of cytoplasmic granules with several enzymes including the serine protease elastase, gelatinase, heparanase, and phospholipase (Lehrer, 2004) . They also produce other toxic proteins, such as myeloperoxidase, bactericidal permeability-increasing protein, and a-defensin (Standish & Weiser, 2009) . Contact of polymorphonuclear neutrophil granulocytes with larger bacterial aggregates resisting phagocytosis like biofilms can trigger the release of the granules in a process termed degranulation (Meyle et al., 2010) leading to an effective removal and killing of cells from the biofilm. Polymorphonuclear neutrophil granulocytes have a variety of mechanisms to clear bacteria exhibiting different degrees of aggregation.
The aim of this study was to investigate interactions between the salivary and the systemic immune systems during the clearance of agglutinated cell bacteremias from the oral cavity. In the current study, Streptococcus gordonii was employed as our model species, as it and other oral streptococci make up > 80% of the species in the early oral biofilm (Rosan & Lamont, 2000) . Streptococcus gordonii is also among the 10 most abundant species in dental plaque (Peterson et al., 2013) . In general, S. gordonii and other Mitis group streptococci are considered commensals mainly responsible for the early colonization of tooth and oral soft tissues (Jakubovics et al., 2014) . Despite their role as commensals and initiators of oral biofilm formation, some of these species, including S. gordonii, are also common etiological agents of infective endocarditis. Hence, we were interested to examine saliva-induced aggregation of S. gordonii and determine its effect upon bacterial killing by phagocytic cells of the innate immune system.
METHODS

Collection of saliva and blood
To study the specific interaction between human saliva and the systemic immune system in a closed model system and to avoid problems with immune incompatibility, all human body fluids used in the presented study were extracted from the same healthy mid-aged male individual.
Saliva was collected on ice 1 h after regular tooth brushing procedure. The serous fraction was separated by centrifugation for 10 min at 4500 g, filtered through a 0.22-lm pore-size polystyrene low-proteinbinding filter (Corning Inc., Corning, NY) and stored at À80°C. Freezing-related precipitates were removed by centrifugation at 21,000 g for 10 min immediately before use.
Freshly collected blood was taken from the right median cubital vein using Sodium Heparin Vacutainer â and Safety-Lok TM System (BD, Franklin Lakes, NJ).
Plasma was generated by centrifugation of fresh heparinized blood for 5 min at 2000 g. The Institutional Review Board of the University of Oklahoma Health Sciences Center approved blood (IRB # 15100) and saliva (IRB # 14327) collection protocols.
Microscopic examination of microbial flora in human saliva
To visualize the planktonic oral microbial flora 1 h after tooth brushing, 1 ml fresh human saliva was incubated with LIVE/DEAD 
Bacterial growth conditions
Streptococcus gordonii DL1 (Pakula & Walczak, 1963) was routinely grown in brain-heart infusion (BHI; BD, Difco) for 16 h at 37°C. A 1 : 30 dilution in fresh BHI medium was further incubated at 37°C until mid-logarithmic growth phase [absorbance at 600 nm (A 600 ) = 0.4], washed twice with sterile phosphatebuffered saline (PBS) for 3 min at 2000 g, and adjusted to A 600 = 0.5 [approx. 7 9 10 8 colony form-
]. This cell density was chosen for technical accuracy because an A 600 = 0.5 is in the center of the linear range of the spectrophotometer, and gives the best correlation between A 600 reading and cell numbers.
Determination of bacterial cell density was performed by plating a 10-fold serial dilution series of cells dispersed with a 5-s low-power sonication (VibraCell VC-50; SONICS â , Newtown, CT). An aliquot of 10 ll was inoculated on BHI agar plates and incubated at 37°C in 5% CO 2 for 24 h. Counting of CFU was performed with an SZ Trinocular Stereo microscope equipped with illuminated base (Olympus).
In vitro salivary aggregation
To investigate saliva-generated bacterial aggregation, 7 9 10 8 CFU of DL1 were resuspended in 1 ml human saliva (processing of saliva was performed as described above) and incubated in a 2-ml reaction tube at 37°C on a rocking 
In vitro blood infection
The influence of salivary aggregation on bacterial clearance in blood was investigated by a whole blood bacterial killing assay (Lancefield, 1957) . A 50-ml DL1 culture from mid-logarithmic growth phase (A 600 = 0.4) was washed twice with sterile PBS and precipitated for 3 min at 2000 g, adjusted to A 600 = 0.5 (approx. 7910 8 CFU ml
À1
) in 1 ml saliva and incubated for 30 min at 37°C on a rocking table, promoting horizontal movement from angle of AE15°at 20 rpm to form saliva-induced bacterial aggregates. Washing the aggregates by gravitational pull four times with sterile PBS stopped the reaction. Where indicated, 5-s low-power ultrasonic treatments were performed to disrupt bacterial aggregates.
One milliliter of fresh human blood as well as freshly prepared human plasma were sealed in 2-ml borosilicate glass vials with silicone rubber caps (Wheaton, Millville, NJ) and infected with aggregated or dispersed cells (approx. 2 9 10 6 CFU ml
, multiplicity of infection % 1) for 3 h in a Hybaid Mini 6 Hybridization Oven (Labnet, Edison, NJ) at 37°C and 6 rpm. At hourly intervals (hourly time-points were chosen for best technical reproducibility), 50-ll aliquots were added to 450 ll of sterile PBS. A 5-s low-power ultrasonic treatment was performed to disrupt bacterial aggregates as well as blood cells and the sample was analyzed for bacterial cell density by serial dilution series in sterile PBS. An aliquot of 10 ll was inoculated on BHI agar plates and incubated at 37°C in 5% CO 2 for 24 h. Colony counts were performed with an SZ Trinocular Stereo microscope equipped with illuminated base (Olympus).
Surface protein composition analysis
To investigate the influence of salivary aggregation and ultrasonic treatment on the protein composition of the bacterial surface during blood infection, binding experiments with saliva and plasma were performed. Fifty-milliliter DL1 cultures from mid-logarithmic growth phase (A 600 = 0.4) were washed twice with sterile PBS for 3 min at 2000 g, resuspended either in 1 ml saliva, plasma, or PBS and incubated for 30 min at 37°C on a rocking table to agitate the cells at an angle of AE15°at 20 rpm. The reaction was stopped by three washing steps with sterile PBS for 3 min at 2000 g. When indicated, a 5-s low-power ultrasonic treatment was performed and saliva-coated cells were subsequently incubated in plasma as described above. Surfacebound proteins were eluted by incubating the cells in 500 ll 0.1 M glycine pH 2.0 for 15 min at room temperature. The cells were removed by centrifugation for 3 min at 6000 g and the protein content of the supernatant was concentrated by precipitation with 50 ll 100% trichloroacetic acid in acetone for 2 h on ice. The precipitate was harvested by centrifugation at 21 000 g for 10 min at 4°C, washed twice with prechilled acetone and resuspended after air-drying in 30 ll reducing sodium dodecyl sulfate sample buffer. The acidic samples were neutralized by addition of 1 ll 1.5 M Tris-HCl pH 8.8, size separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (Laemmli, 1970) , and visualized by Coomassie Brilliant Blue G-250 staining (Kang et al., 2002) .
In vitro phagocytosis assay
To investigate if the observed difference in bacterial clearance in blood is caused by phagocytosis efficiency or extracellular killing, a gentamycin protection assay was performed (Medina et al., 2003) . Salivainduced bacterial aggregates of DL1 were prepared as described above.
Human granulocytes were always prepared from fresh human blood on a daily basis using the Polymorphprep TM system (Axis-Shield, Dundee, Scotland) following the supplier's manual. The purified cells were resuspended in HyClone â RPMI-1640 Medium + , multiplicity of infection % 1) for 3 h in a Hybaid Mini 6 Hybridization Oven (Labnet) at 37°C and 6 rpm.
At hourly intervals 100-ll aliquots were taken, added to 900 ll of fresh RPMI-1640 10% FCS containing 200 lg ml À1 gentamycin sulfate (Calbiochem, Merck KGaA, Darmstadt, Germany) and incubated for 5 min in ice water to stop phagocytosis and killing processes. Extracellular bacteria were subsequently killed by incubating the samples for 1 h at 37°C in the presence of 200 lg gentamycin. Killing efficiency was tested in separate experiments (data not shown). Intracellular bacteria were collected by centrifugation after three washing steps using sterile PBS at 300 g followed by 5 s of low-power ultrasonic treatment to disrupt human granulocytes and release the intracellular bacteria. Ten microliters of serially diluted cells was inoculated on BHI agar plates and incubated at 37°C in 5% CO 2 for 24 h. Colony counting was performed with an SZ Trinocular Stereo microscope equipped with illuminated base (Olympus). At the same time-points, 50-ll aliquots were added to 450 ll of sterile PBS to determine the overall bacterial count of each infection. A 5-s low-power ultrasonic treatment was performed to disrupt bacterial aggregates as well as granulocytes and the sample was analyzed for remaining bacterial cell density by colony counting. An aliquot of 10 ll was inoculated on BHI agar plates and incubated at 37°C and 5% CO 2 for 24 h. Colony counting was performed with an SZ Trinocular Stereo microscope equipped with illuminated base (Olympus).
Where indicated, the specific irreversible inhibitor of serine proteases 4-(2-aminoethyl)benzenesulfonylfluoride (AEBSF; Calbiochem) was added in a final concentration of 500 lM to the infection assay.
In vitro de-aggregation by granulocyte proteases
To determine how granulocytes disrupt saliva-induced bacterial aggregates during phagocytosis, a de-aggregation assay with granule components was performed (Standish & Weiser, 2009 ).
Saliva-induced bacterial aggregates of DL1 were prepared as described above and resuspended in 800 ll sterile PBS.
Human granulocytes were prepared as described above, resuspended in HyClone â RPMI-1640 Medium + 2.05 mM L-glutamine (Thermo Scientific) without FCS and adjusted to approx. 4 9 10 7 cells ml À1 by
Trypan Blue dye exclusion using an Improved Neubauer chamber (Hausser Scientific).
To degranulate the primary granules, 1 ml cell suspension in a 2-ml reaction tube was treated with 10 ng ml À1 phorbol 12-myristate 13-acetate (Sigma Aldrich, St Louis, MO) for 30 min at 37°C and 20 rpm on a rocking table. To degranulate primary as well as azurophilic granules, the cells were first treated with 5 lg ml À1 cytochalasin D (Sigma Aldrich) for 5 min at 37°C and subsequently with 1 lM N-Formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP) (Sigma Aldrich) for 30 min at 37°C and 20 rpm. The cells were removed by centrifugation at 600 g for 10 min at 20°C and the supernatant was stored overnight at À80°C. Two hundred microliters of granula-extract was added to 800 ll DL1 aggregates in PBS and incubated for 2 h at 37°C on a rocking table, promoting horizontal movement from angle of AE15°at 20 rpm. To inhibit proteolytic activity in the primary/azurophilic granula preparation, 500 lM AEBSF (Calbiochem) was added. At the indicated time-points, 100-ll aliquots were added to 900 ll sterile PBS and the deaggregation of the preformed bacterial aggregates was measured by the increase of detectable CFU.
To investigate the influence of each of the three proteases secreted during azurophilic granula release, a de-aggregation assay with specific protease inhibitors was performed. Where indicated, 500 lM AEBSF (Calbiochem), 100 lM Elastase Inhibitor IV (HNE IV; Calbiochem), and 200 lM Chymostatin (Sigma Aldrich) were added to the extract of primary and azurophilic granules and incubated for 5 min at 37°C before the addition of preformed bacterial aggregates.
Macroscopic examination was performed vertically with 1-ml samples in 2-ml reaction tubes using a Nikon D80 equipped with AT-X 100 PRO D macro lens (Tokina, Tokyo, Japan) in a BioDoc-It â Imaging System (UVP, Upland, CA) with a UV to white light converter plate for proper illumination.
Statistical analysis
Statistical significance was calculated using a twosided Student's t-test, with P-values <0.05 considered as statistically significant. Mathematically rounded Pvalues of the individual experiments are given in the corresponding figure legend.
RESULTS
Organizational state of bacteria in human saliva
To determine the organizational state of the bacterial flora in human saliva in vivo, a microscopic examination of freshly collected human saliva was performed (Fig. 1A) . A bacteria-specific fluorescent viability stain in combination with a eukaryotic membrane stain was applied to identify bacterial as well as human cells and visualize bacterial viability (Fig. 1B) . The microscopic examination indicated that nearly all bacterial cells were viable and revealed two major reservoirs of bacterial cells in human saliva. Shed buccal epithelial cells were frequently associated with high numbers of rod and spherically shaped bacterial cells in agreement with previous reports (Rudney et al., 2005) (Fig. 1C) . Planktonic cells present as single cells or small clusters were detected in addition to more or less spherical aggregates with an average diameter of approximately 20 lm probably caused by salivary agglutination (Fig. 1D) . The red-labeled components are the nuclei of shed buccal epithelial cells, suggesting that these cells are membrane compromised or possibly dead.
Development of an in vitro model of salivary agglutination
To investigate the biological significance of salivainduced bacterial agglutination in a controlled environment, an in vitro model was developed using sterile filtered human serous saliva and the welldescribed oral streptococcal strain of S. gordonii DL1. A defined number of vital bacterial cells was resuspended in the serous fraction of human saliva and incubated at 37°C with a reproducible amount of shear forces. The formation of cell aggregates was followed over time by the decrease of detectable CFU in comparison to the same sample after the aggregates were disrupted by sonication ( Fig. 2A) . After 5 min of incubation, a significant 13-fold reduction in CFU could be detected, that further decreased up to 45-fold after 20 min. The observed reduction in CFU was specific to bacterial agglutination, as no reductions in viable cell counts could be observed during the maximal incubation time of 60 min.
To characterize the related aggregate morphology, microscopic observations of the samples were performed during the experiment and average aggregate sizes were determined (Fig. 2B) . The in vitro incubation of bacterial cells for 5 min in saliva resulted in a population of aggregates with a diameter of 5-70 lm with a major group around 15 lm. After 30 min of incubation a more heterogeneous distribution of aggregate sizes up to 160 lm could be observed with an average of 45 lm and several <25 lm. When comparing the size distribution of the single-species aggregates in the in vitro model to the in vivo multispecies aggregates in saliva (Fig. 1D) , a better representation of the range was observed at 30 min. The 5 min time-point seemed to have a more even distribution, but we did not observe larger aggregates > 100 lm. Subsequent experiments were therefore performed with in vitro aggregated cells incubated in saliva for 30 min.
Microscopic examination also confirmed that the initial culture exhibited typical streptococcal cell chains, whereas salivary agglutination led to the formation of more or less spherical aggregates that could be efficiently disrupted into bunches of two to ten cells by mild sonication (Fig. 2C) . From these results, we concluded that these conditions could serve as a suitable in vitro approach to mimic salivainduced bacterial agglutination for comparative studies with human blood components. 
Salivary agglutination leads to accelerated clearance of bacteria in blood
To investigate the influence of salivary agglutination on bacterial survival in blood, we employed our in vitro model to compare saliva-treated aggregates and dispersed bacteria. The bacterial preparations were incubated in freshly drawn human blood as well as freshly prepared human plasma as a growth control. The bacterial survival was followed over time and calculated as percentage of survival to the initial CFU (Fig. 3A) . After 1 h of incubation a significant 3.8-fold increase in the clearance of aggregated bacteria could be observed if compared with the non-aggregated control set-up. This initial 'killing-gap' in the dispersed sample resulted in a constant difference of bacterial load in comparison with the incubation with aggregated bacteria. In contrast, there was no detectable difference in viability and growth in the plasma controls between aggregated and disrupted bacterial aggregates for the duration of the experiment.
To address the possibility that sonication induced changes in bacterial surface-protein composition leading to differences in the interaction with salivary or plasma proteins, a surface protein composition analysis was performed (Fig. 3B) . One-dimensional separation of acidic surface elutions showed no obvious differences in the binding behavior of saliva and plasma proteins to the bacterial surface of aggregated and dispersed bacteria. This suggests that the greater survival of dispersed cells in blood was unlikely to be attributable to surface protein modifications introduced through sonication.
Salivary aggregation of bacteria leads to accelerated phagocytosis by granulocytes
We were next interested to determine whether the increased killing efficiency of salivary aggregates could be attributed to differences in phagocytosis. A defined number of freshly purified human granulocytes were infected with aggregated and dispersed bacteria and we similarly observed significantly greater killing of bacterial aggregates (Fig. 4A) . This result was consistent with a gentamycin protection assay, which revealed a 100-fold higher phagocytosis efficiency of saliva-aggregated bacteria compared with non-aggregated bacteria during the first hour of infection (Fig. 4B) , pointing towards accelerated recognition of the bacterial cells by the neutrophils. A possible increased initial killing before the 1 h timepoint of the internalized non-aggregated cells is unlikely because non-aggregated DL1 has been shown to survive quite efficiently inside polymorphonuclear neutrophil granulocytes (Yajima et al., 2009) . The bacterial aggregates were rapidly phagocytosed at the beginning of the assay with a decrease of detectable intracellular bacteria after 3 h of infection. In contrast, phagocytosis of the dispersed bacteria occurred slowly, following a linear course. No significant differences in viability and growth in the media controls were detected. This suggests that accelerated phagocytosis and subsequent intracellular killing caused the observed increase in the clearance efficiency of aggregated bacteria in human blood by granulocytes.
Granulocyte proteases are able to disrupt salivainduced bacterial aggregates
To investigate how granulocytes are able to efficiently take up bacterial cells out of a compact salivary aggregate, granulocyte-derived serine proteases were analyzed for their ability to disrupt bacterial aggregates. Preformed saliva-induced bacterial aggregates were treated with the content of either primary or primary + azurophilic granules and in combination with the specific, irreversible serine protease inhibitor AEBSF. Changes in aggregation were followed over time by quantifying cfu. In all three treatments, deaggregation could be observed over the course of the assay (Fig. 5A) . The aggregates treated with primary granule components as well as primary + azurophilic granules in combination with AEBSF both showed only a minor de-aggregation, probably caused by the applied shear forces. However, the primary + azurophilic granule components without inhibitor showed a significant four-fold increase in detectable CFU after 60 min of incubation (Fig. 5A) . As control, we also confirmed that the different granule preparations as well as AEBSF did not affect bacterial viability and growth (data not shown). To confirm this result, a direct macroscopic examination of the reaction was performed (Fig. 5B) . After 60 min of incubation, an obvious increase of the optical density and a decrease of aggregation size could be observed.
To distinguish the contribution of the different granulocyte proteases to the degradation of salivainduced bacterial aggregates, we further tested a variety of specific protease inhibitors (Fig. 6A) . We detected a significant reduction in the amount of detectable CFU after 60 min of incubation using human neutrophil elastase inhibitor HNE IV, which was further enhanced in combination with the cathepsin G inhibitor chymostatin. Treatment with chymostatin alone was not sufficient to significantly reduce the de-aggregating effect of azurophilic granule components, which indicates neutrophil elastase as a major factor responsible for the observed lysis of salivary aggregates. No significant effect on bacterial viability and growth could be detected using the different protease inhibitor combinations (data not shown). These observations could be confirmed independently by a macroscopic examination of the reaction tubes after 60 min of incubation (Fig. 6B) . A significant increase of the optical density as a result of aggregate degradation could only be seen in the positive control without any inhibitor and in the sample treated with the cathepsin-G-specific inhibitor chymostatin.
Granulocyte protease activity is essential to take up and kill saliva aggregated bacteria
To investigate the contribution of granulocyte proteases to phagocytosis and the killing of saliva-aggregated bacteria, a phagocytosis assay was performed in the presence of the AEBSF (Fig. 7A) . Protease inhibitor treatment resulted in an increase in the amount of bacterial cells over the time of infection that was comparable with the plasma control. In contrast, the samples without inhibitor exhibited a significant nine-fold decrease in bacterial load after 3 h of infection.
This observation could be confirmed by the determination of phagocytosis efficiency (Fig. 7B) . In the presence of AEBSF only a few intracellular bacteria could be detected. In comparison, the infection without inhibitor treatment yielded a significant 500-fold increase of detectable intracellular bacteria after 1 h that slowly decreased over time, demonstrating the importance of granulocyte proteases during the phagocytic uptake of saliva aggregated bacteria. 
DISCUSSION
A transient bacteraemia as a consequence of a temporary breeched oral mucosal barrier is a common event induced by surgical or dental procedures, as well as daily oral hygiene or ingestion of food (Lockhart & Durack, 1999; Lockhart et al., 2008) . Phagocytic cells of the innate immune system are usually very efficient in the removal of these bacterial invaders (Zhang et al., 2000) . The effectiveness of this defense response, among other factors, is influenced by the size of the bacterial cell, as well as cellular aggregation state (Weiser, 2013) . The size of bacteria, especially streptococci, varies by the actual size of the individual cell, but can also vary as a result of incomplete separation of daughter cells leading to longer streptococcal chains (Zapun et al., 2008) . For the nasopharyngeal pathogen Streptococcus pneumoniae, an increase in cell-chain length was associated with increased complement deposition on the bacterial surface in vitro and promoted complementdependent clearance during systemic infection of mice. In addition, a decrease in cell-chain length as observed with several mutants, provided a competitive advantage in vivo when compared with wild-type cells. Subsequently, minimization of S. pneumoniae leads to less effective killing by opsonophagocytosis and absence (dashed lines) of 2 9 10 6 granulocytes in RPMI with 10% fetal calf serum. (B) Corresponding data for determination of intracellular bacteria. Data represent averages and standard deviations from three independent experiments (*P < 0.04). (Dalia & Weiser, 2011) . Consequently microbial size seems to be proportional to the innate immune system's ability to initiate complement deposition and clearance. It is therefore expected that host-derived mechanisms exist that promote aggregation of bacteria to prevent uncontrolled spreading of bacterial invaders and to provide an ideal recognition by phagocytic cells of the innate immune system. The herein observed salivary agglutination bridges two important bacterial clearance mechanisms. The main route for removal of bacteria from the oral cavity through shear-force-dependent clearance by salivary flow and swallowing, with the gastric juice killing most of the bacterial load (Scannapieco, 1994; Zhu et al., 2006) and the salivary agglutination-induced recognition and clearance of oral bacteria by polymorphonuclear neutrophil granulocytes in case the mucosal barrier is breeched and bacterial aggregates enter the blood. Published work from others (Boackle et al., 1993; Leito et al., 2011) and the herein presented data clearly support that salivary agglutination primes oral bacteria for better clearance, as single cells are more resistant to polymorphonuclear neutrophil granulocyte killing as presented in Fig. 4 and Young Lee et al. (2006) . Overall, the ability of oral streptococci to form a biofilm as well as their successful integration into an existing biofilm structure and the salivaryinduced agglutination for clearance seem to be competing events. The structural biofilm components, also referred to as biofilm matrix, include polysaccharides, proteins, extracellular DNA and lipids as well as some host components, and may have potent resistance against host defense mechanisms and shear-forcedependent clearance. Biofilms can protect embedded oral streptococci from being taken up by polymorphonuclear neutrophil granulocytes (among other advantages). In addition, physical and diffusion limitations might prevent the degradation of the structural components inside the biofilm. This is in contrast to salivary-induced agglutination, which potentially leaves the bacteria inside the agglutinated structure seemingly protected, but our results demonstrate that the agglutinated structures can be readily digested by the polymorphonuclear neutrophil granulocytes for further clearance.
In general, it seems that microbes either try to remain as small as possible, perhaps also by avoiding biofilm development until a secure host-niche is reached and subsequently either evade the hostimmune system completely by becoming an intracellular pathogen, grow into larger filamentous aggregates as described for E. coli, or most-likely develop into a biofilm (Weiser, 2013) . This is further supported by investigations on the ideal particle size for phagocytosis using polymeric microspheres. Diameters between 2 to 3 lm are most effectively phagocytized (Champion et al., 2008) . Since coccoid bacteria like streptococci and staphylococci are smaller than the ideal size for phagocytosis (average size between 0.5 to 1.5 lm) (Doshi & Mitragotri, 2010) , remaining in the single cell state would be a perfect strategy for survival and dissemination. Effective phagocytosis of particle sizes between 2 to 3 lm is determined by the attachment to membrane ruffles found on macrophages suggesting a strong correlation between initial attachment and phagocytosis efficiency (Champion et al., 2008) . Although the observed diameter of salivary-induced aggregates is bigger (around 20 lm) than the ideal size for phagocytosis, the study by Doshi and Mitragotri found an increase in attachment for larger particle dimensions in the 12 lm range (Doshi & Mitragotri, 2010) . Larger particle sizes or particle aggregates were not investigated in this study. However, increase in the surface area might allow additional macrophages to surround cell aggregates.
A similar strategy to avoid a certain aggregate size can also be observed with oral bacteria, which are known to colonize the tooth and mucosal surfaces as elaborate oral biofilms (Maddi & Scannapieco, 2013) and can also be found inside oral epithelial cells (Rudney et al., 2005) . Furthermore, certain oral streptococci are known to secrete IgA proteases (Yokota & Oguma, 1997) , which cleave specifically human sIgA1 at the hinge region to produce Fab and Fc fragments, so preventing sIgA-dependent agglutination. This protease function is of potential ecological importance in the oral cavity and it has been suggested that the protease aids in the pathogenic potential of bacteria whose systemic entry is the mucosal surface (Tyler & Cole, 1998) .
Conversely, the host has developed an elaborate net of aggregating molecules, which individually target free-floating single cells, but also interact with each other to form larger molecular aggregates (Scannapieco, 1994) increasing the chance to trap oral bacteria. Interestingly, while salivary agglutination mainly aids in the removal of bacteria by swallowing, it also seems to provide the systemic innate immune system with an advantage in case the mucosal barrier is breeched. In particular, the role of salivary agglutinin has been confirmed as a major mediator in this process. Salivary agglutinin is a protein complex consisting of the scavenger receptor cysteine-rich glycoprotein gp340, secretory immunoglobulin A, and an 80-kDa protein (Loimaranta et al., 2005) , which interacts with streptococci and other bacteria as part of the host innate defense system at mucosal surfaces (Ericson & Rundegren, 1983; Oho et al., 1998; Prakobphol et al., 2000) . The relative non-discriminate polymicrobial aggregation allows for a rigorous capture and clearance even for bacteria, which might not trigger a robust innate immune response on their own. The herein used S. gordonii DL1 interacts with salivary agglutinin through sialic acid binding adhesin Hsa and antigen I/II family adhesins SspA and SspB (Loimaranta et al., 2005) . The observed salivary agglutination in our in vitro model is therefore most likely dependent upon salivary agglutinin. Besides its general aggregation ability with diverse bacterial species, salivary agglutinin is able to activate the complement system (Boackle et al., 1993; Leito et al., 2011) . The activation occurs mainly through the lectin pathway involving the recognition of mannose residues on pathogens and commensal bacteria by the mannosebinding protein Mannose-binding lectin (MBL). The classical activation through complement recognition molecule C1q only plays a minor role in the process (Leito et al., 2011) . Subsequently, complement activation leads to opsonization and chemotactic attraction of innate immune cells initiating phagocytic clearance.
As shown here, salivary agglutination leads to the effective killing of S. gordonii. This was associated with a rapid intracellular accumulation of S. gordonii inside polymorphonuclear neutrophil granulocytes, indicating that the saliva-driven aggregation did not interfere with phagocytosis. The incubation with components usually released by degranulating polymorphonuclear neutrophil granulocytes was associated with a visible deaggregation that could be inhibited by the serine-protease inhibitor AEBSF, suggesting an active degradation of salivary agglutinin structures responsible for aggregation. As a consequence of AEBSF inhibition, no intracellular bacteria were detected. The herein observed events may suggest that salivary agglutination leads to an ideal size for recognition by the host defense system once bacterial aggregates enter the circulatory system. As a first line of defense, polymorphonuclear neutrophil granulocytes are able to recognize the aggregates probably by complementmediated chemotaxis and with the help of serine proteases are able to de-aggregate the cells to a more manageable size for easy phagocytosis and subsequent killing in the phagolysosome. Membrane-bound human neutrophil elastase and cathepsin G (Owen et al., 1995) seem to be responsible for the observed degradation. Although not determined here, killing via the generation of reactive oxygen species during oxidative burst is also a likely mechanism used by polymorphonuclear neutrophil granulocytes as shown for Staphylococcus aureus (Standish & Weiser, 2009 ), but might be ineffective againt streptococci because they are known to produce copious amounts of H 2 O 2 themselves (Zhu & Kreth, 2012) and have potent resistant mechanisms in place (Xu et al., 2014) .
A limitation of our study is the use of one blood donor. However, our results are consistent with earlier reports investigating S. gordonii polymorphonuclear neutrophil granulocyte interactions (Young Lee et al., 2006; Yajima et al., 2009) and with a report investigating the effect of bacterial size minimization on complement evasion (Dalia & Weiser, 2011) .
In conclusion, the bacterial size and aggregate status are important factors for recognition by the host defense system. The herein presented data not only support the important role for salivary agglutination in the clearance of bacteria when entering the circulatory system, it also demonstrates in general the efficient interaction of the oral salivary immune defense and the systemic immune system against invading bacterial cells. Studies investigating innate immune system-pathogen interaction should consider the actual appearance of bacteria in the host for a better understanding of mechanisms leading to eventual clearance of disseminating microbial species.
